China May Set Reference Prices, Adjust Price Caps For High-Cost Drugs
This article was originally published in PharmAsia News
Executive Summary
China’s National Development and Reform Commission has publicly stated that drug price control method will change from retail price caps to reference prices and that some high-priced medicines will undergo retail price limit adjustment.